Skip to content

13F-HR/A filed by Davidson Kempner Capital Management LP

Davidson Kempner Capital Management LP filed this 13F-HR/A for the quarter ended 2026-06-30, accepted by EDGAR 2026-11-16 19:54:47 UTC, with 1 holding row worth $156,953,358.

Accession
0001595082-26-000110
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q2 2026

A holdings report, amendment of type new holdings, 1 entries on the cover page, a total value of $156,953,358 stated on the cover page (in dollars after the unit check, H1), rows summing to $156,953,358 with VALUE read as dollars as filed, 13F file number 028-16184. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
APOGEE THERAPEUTICS INC COM03770N101Stock1,182,501$156,953,358dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001595082-26-000069 base2026-08-14acceptance time not in the bulk data set
13F-HR/A 0001595082-26-000108 added2026-11-16
13F-HR/A 0001595082-26-000109 added2026-11-16
13F-HR/A 0001595082-26-000110this filing2026-11-16